Detection of resistance mechanisms in cerebrospinal fluid for EGFR-mutant, ALK- and ROS1-rearranged non-small cell lung cancer patients with central nervous system (CNS) progression after evidence of prior CNS benefit on relevant tyrosine kinase inhibitors
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Diagnostic
Locations
Georgetown University
University of Colorado Hospital
USC (Norris Hospital)
Study ID
Protocol Number: 20-1193
More information available at ClinicalTrials.gov: NCT05116618
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers